{"entity":{"type":"insider","cik":"0001293577","url":"/insider/0001293577","json_url":"/insider/0001293577.json","name":"Katz Richard D","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":5,"n_filings":5,"first":"2011-08-12","last":"2018-01-12","span_basis":"filed_date"},"name_variants":[{"name":"Katz Richard D","source":"filing","n_filings":5,"first_seen":"2011-08-12","last_seen":"2018-01-12"}],"transactions":[{"id":9282310,"accession":"0001293577-18-000003","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001293577-18-000003","line_url":"/filing/0001293577-18-000003#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":"0001293577","owner_name":"Katz Richard D","owner_url":"/insider/0001293577","role":"Officer (Vice President and CFO)","officer_title":"Vice President and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104435.0,"shares_display":"104,435","price_per_share":0.1647,"price_display":"0.16","price_state":"stated","total_value":17200.4445,"total_display":"17,200.44","shares_owned_after":193959.0,"shares_owned_after_display":"193,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-10","filed_date":"2018-01-12","scope":"insider"},{"id":6736165,"accession":"0001293577-18-000002","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001293577-18-000002","line_url":"/filing/0001293577-18-000002#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":"0001293577","owner_name":"Katz Richard D","owner_url":"/insider/0001293577","role":"Officer (Vice President and CFO)","officer_title":"Vice President and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":104435.0,"shares_display":"104,435","price_per_share":0.1647,"price_display":"0.16","price_state":"stated","total_value":17200.4445,"total_display":"17,200.44","shares_owned_after":193959.0,"shares_owned_after_display":"193,959","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-09","filed_date":"2018-01-12","scope":"insider"},{"id":6838208,"accession":"0001293577-18-000001","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001293577-18-000001","line_url":"/filing/0001293577-18-000001#line-1","is_derivative":false,"issuer_cik":"0001105533","issuer_name":"ARGOS THERAPEUTICS INC","issuer_ticker":"ARGS","issuer_name_source":null,"issuer_url":"/issuer/0001105533","owner_cik":"0001293577","owner_name":"Katz Richard D","owner_url":"/insider/0001293577","role":"Officer (Vice President and CFO)","officer_title":"Vice President and CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":101228.0,"shares_display":"101,228","price_per_share":0.1634,"price_display":"0.16","price_state":"stated","total_value":16540.6552,"total_display":"16,540.66","shares_owned_after":298394.0,"shares_owned_after_display":"298,394","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-01-03","filed_date":"2018-01-05","scope":"insider"},{"id":9161090,"accession":"0001181431-11-046437","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001181431-11-046437","line_url":"/filing/0001181431-11-046437#line-3","is_derivative":false,"issuer_cik":"0000902622","issuer_name":"ICAGEN INC","issuer_ticker":"ICGN","issuer_name_source":null,"issuer_url":"/issuer/0000902622","owner_cik":"0001293577","owner_name":"Katz Richard D","owner_url":"/insider/0001293577","role":"Officer (Ex VP, Fin & Corp, CFO & Treas)","officer_title":"Ex VP, Fin & Corp, CFO & Treas","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8.0,"shares_display":"8","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":47.68,"total_display":"47.68","shares_owned_after":75972.0,"shares_owned_after_display":"75,972","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-18","filed_date":"2011-08-22","scope":"insider"},{"id":9149325,"accession":"0001181431-11-045317","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001181431-11-045317","line_url":"/filing/0001181431-11-045317#line-2","is_derivative":false,"issuer_cik":"0000902622","issuer_name":"ICAGEN INC","issuer_ticker":"ICGN","issuer_name_source":null,"issuer_url":"/issuer/0000902622","owner_cik":"0001293577","owner_name":"Katz Richard D","owner_url":"/insider/0001293577","role":"Officer (Ex VP, Fin & Corp, CFO & Treas)","officer_title":"Ex VP, Fin & Corp, CFO & Treas","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36.0,"shares_display":"36","price_per_share":5.96,"price_display":"5.96","price_state":"stated","total_value":214.56,"total_display":"214.56","shares_owned_after":77056.0,"shares_owned_after_display":"77,056","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-08-10","filed_date":"2011-08-12","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":5,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":5},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001105533","name":"ARGOS THERAPEUTICS INC","url":"/issuer/0001105533","role":"Officer (Vice President and CFO)","n_filings":3,"first_seen":"2018-01-05","last_seen":"2018-01-12"},{"type":"issuer","type_label":"ISSUER","cik":"0000902622","name":"ICAGEN INC","url":"/issuer/0000902622","role":"Officer (Ex VP, Fin & Corp, CFO & Treas)","n_filings":2,"first_seen":"2011-08-12","last_seen":"2011-08-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001293577","retrieved_at":"2026-08-21T13:55:49+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}